GGrantIndex
Sort

51,570 grants matching autoimmune disease

Engineering and Analysis of T cell CD3 and IL2R Signals

$568,907
Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2006 · AI

The Role of Polyamines and Hypusine in Beta-Cell Dysfunction

$568,857
Sarah A. Tersey · University Of Chicago · R01 · FY2024 · DK

Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation

$568,784
Lance A Liotta · George Mason University · R01 · FY2016 · AR

Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation

$568,784
Lance A Liotta · George Mason University · R01 · FY2017 · AR

Tumor and host immune signatures associated with patient outcomes to GD2 chemoimmunotherapy in neuroblastoma

$568,722
Kelly C Goldsmith · Emory University · R01 · FY2025 · CA

Trainet: Diabetes Type 1 Prevention

$568,659
Peter A Gottlieb · University Of Colorado Denver · U01 · FY2009 · DK

Human copy number polymorphism and severe malaria

$568,642
Jeffrey A. Bailey · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · AI

Elucidating the Role of the Intestinal Microbiota in Pathogen Resistance

$568,632
Robert A Britton · Michigan State University · U19 · FY2012 · AI

Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant

$568,505
Jarrod Dudakov · Fred Hutchinson Cancer Research Center · R01 · FY2021 · HL

Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant

$568,505
Jarrod Dudakov · Fred Hutchinson Cancer Research Center · R01 · FY2020 · HL

Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant

$568,505
Jarrod Dudakov · Fred Hutchinson Cancer Research Center · R01 · FY2019 · HL

HT screens for the disruption of the T cell receptor CD3 interface

$568,500
Luc Teyton · Scripps Research Institute, The · R01 · FY2011 · AI

Contribution and interplay of CXCR4 and integrins in central B cell tolerance

$568,467
Roberta Pelanda · University Of Colorado Denver · R01 · FY2025 · AI

Contribution and interplay of CXCR4 and integrins in central B cell tolerance

$568,467
Roberta Pelanda · University Of Colorado Denver · R01 · FY2024 · AI

Stress Effects on Virus Protein induced Inflammation and Sickness Behavior

$568,411
Marshall Vance Williams · Ohio State University · R01 · FY2017 · AI

Stress Effects on Virus Protein induced Inflammation and Sickness Behavior

$568,411
Marshall Vance Williams · Ohio State University · R01 · FY2019 · AI

Stress Effects on Virus Protein induced Inflammation and Sickness Behavior

$568,411
Marshall Vance Williams · Ohio State University · R01 · FY2016 · AI

Promoter interactome-aided mapping of unexplored CVID genetic landscapes

$568,348
Neil David Romberg · Children'S Hosp Of Philadelphia · R01 · FY2020 · AI

Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots

$568,324
Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2022 · AI

Activation and regulation of autoreactive B cells in health and disease

$568,221
Mark J Shlomchik · Yale University · R01 · FY2012 · AI

TNF-receptors and programmed cell death in regulation of autoimmunity

$568,218
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR

TNFR1 in the regulation of autoinflammatory diseases

$568,218
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR

Leukocyte Adhesion Receptors Mac-1 and P150,95

$568,200
Timothy A Springer · Immune Disease Institute, Inc. · R01 · FY2007 · AI

Mechanisms underlying macrophage action in nerve regeneration and degeneration

$568,173
Richard E Zigmond · Case Western Reserve University · R01 · FY2019 · NS

Finding the optimal balance of immunotherapy efficacy and toxicity.

$568,167
David Eric Gerber · Ut Southwestern Medical Center · U01 · FY2023 · AI